BIBLIOGRAPHY

Adamis, A. P., Miller, J. W., Bernal, M. T., D'Amico, D. J., Folkman, J., Yeo, T. K., and Yeo, K. T. (1994). Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. American Journal of Ophthalmology 118, 445-50.

Adamis, A. P., Shima, D. T., Tolentino, M. J., Gragoudas, E. S., Ferrara, N., Folkman, J., D'Amore, P. A., and Miller, J. W. (1996). Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Archives of Ophthalmology 114, 66-71.

Aiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., and et al. (1994). Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. New England Journal of Medicine 331, 1480-7.

Aiello, L. P., Pierce, E. A., Foley, E. D., Takagi, H., Chen, H., Riddle, L., Ferrara, N., King, G. L., and Smith, L. E. (1995). Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proceedings of the National Academy of Sciences of the United States of America 92, 10457-61.

Alon, T., Hemo, I., Itin, A., Pe'er, J., Stone, J., and Keshet, E. (1995). vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nature Medicine 1, 1024-8.

Anderson, D., Koch, C. A., Grey, L., Ellis, C., Moran, M. F., and Pawson, T. (1990). Binding of SH2 domains of phospholipase C gamma 1, GAP, and Src to activated growth factor receptors. Science 250, 979-82.

Andersson, M., Ostman, A., Backstrom, G., Hellman, U., George-Nascimento, C., Westermark, B., and Heldin, C. H. (1992). Assignment of interchain disulfide bonds in platelet-derived growth factor (PDGF) and evidence for agonist activity of monomeric PDGF. Journal of Biological Chemistry 267, 11260-6.

Aprelikova, O., Pajusola, K., Partanen, J., Armstrong, E., Alitalo, R., Bailey, S. K., McMahon, J., Wasmuth, J., Huebner, K., and Alitalo, K. (1992). FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter. Cancer Research 52, 746-8.

Armstrong, E., Kastury, K., Aprelikova, O., Bullrich, F., Nezelof, C., Gogusev, J., Wasmuth, J. J., Alitalo, K., Morris, S., and Huebner, K. (1993). FLT4 receptor tyrosine kinase gene mapping to chromosome band 5q35 in relation to the t(2;5), t(5;6), and t(3;5) translocations. Genes, Chromosomes & Cancer 7, 144-51.

Asahara, T., Bauters, C., Zheng, L. P., Takeshita, S., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M. (1995). Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92, II365-71.

Auerbach, R., Alby, L., Morrissey, L. W., Tu, M., and Joseph, J. (1985). Expression of organ-specific antigens on capillary endothelial cells. Microvascular Research 29, 401-11.

Auerbach, W., and Auerbach, R. (1994). Angiogenesis inhibition: a review. Pharmacology& Therapeutics 63, 265-311.

Bacic, M., Edwards, N. A., and Merrill, M. J. (1995). Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues. Growth Factors 12, 11-5.

Baird, A., and Durkin, T. (1986). Inhibition of endothelial cell proliferation by type beta-transforming growth factor: interactions with acidic and basic fibroblast growth factors. Biochemical & Biophysical Research Communications 138, 476-82.

Baird, A., and Ling, N. (1987). Fibroblast growth factors are present in the extracellular matrix produced by endothelial cells in vitro: implications for a role of heparinase-like enzymes in the neovascular response. Biochemical & Biophysical Research Communications 142, 428-35.

Banai, S., Jaklitsch, M. T., Shou, M., Lazarous, D. F., Scheinowitz, M., Biro, S., Epstein, S. E., and Unger, E. F. (1994). Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs. Circulation 89, 2183-9.

Barbacid, M. (1993). Nerve growth factor: a tale of two receptors. Oncogene 8, 2033-42.

Barleon, B., Sozzani, S., Zhou, D., Weich, H. A., Mantovani, A., and Marme, D. (1996). Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87, 3336-43.

Basilico, C., and Moscatelli, D. (1992). The FGF family of growth factors and oncogenes. Advances in Cancer Research 59, 115-65.

Ben-Av, P., Crofford, L. J., Wilder, R. L., and Hla, T. (1995). Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1:a potential mechanism for inflammatory angiogenesis. FEBS Letters 372, 83-7.

BenEzra, D. (1978). Neovasculogenic ability of prostaglandins, growth factors, and synthetic chemoattractants. American Journal of Ophthalmology 86, 455-61.

Benninghoff, A., Hartmann, A., and Hellmann, T. (1930). Handbuch der mikroskopischen Anatomie des Menschen. (Berlin: Springer).

Berkman, R. A., Merrill, M. J., Reinhold, W. C., Monacci, W. T., Saxena, A., Clark, W. C., Robertson, J. T., Ali, I. U., and Oldfield, E. H. (1993). Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. Journal of Clinical Investigation 91, 153-9.

Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F., and Senger, D. R. (1992). Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Molecular Biology of the Cell 3, 211-20.

Bikfalvi, A., Sauzeau, C., Moukadiri, H., Maclouf, J., Busso, N., Bryckaert, M., Plouët, J., and Tobelem, G. (1991). Interaction of vasculotropin/vascular endothelial cell growth factor with human umbilical vein endothelial cells: binding, internalization, degradation, and biological effects. Journal of Cellular Physiology 149, 50-9.

Bishop, J. M. (1991). Molecular themes in oncogenesis. Cell 64, 235-48.

Blei, F., Wilson, E. L., Mignatti, P., and Rifkin, D. B. (1993). Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. Journal of Cellular Physiology 155, 568-78.

Blood, C. H., and Zetter, B. R. (1990). Tumor interactions with the vasculature:angiogenesis and tumor metastasis. Biochimica et Biophysica Acta 1032, 89-118.

Bocchietto, E., Guglielmetti, A., Silvagno, F., Taraboletti, G., Pescarmona, G. P., Mantovani, A., and Bussolino, F. (1993). Proliferative and migratory responses of murine microvascular endothelial cells to granulocyte-colony-stimulating factor. Journal of Cellular Physiology 155, 89-95.

Boensch, C., Kuo, M. D., Connolly, D. T., Huang, S. S., and Huang, J. S. (1995). Identification, purification, and characterization of cell-surface retention sequence-binding proteins from human SK-Hep cells and bovine liver plasma membranes. Journal of Biological Chemistry 270, 1807-16.

Borg, J. P., deLapeyriere, O., Noguchi, T., Rottapel, R., Dubreuil, P., and Birnbaum, D. (1995). Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase. Oncogene 10, 973-84.

Borgström, P., Hillan, K. J., Sriramao, P., and Ferrara, N. (in press). Complete inhibition of angiogenesis and growth of micro tumors by anti-VEGF neutralizing antibodies. Novel concepts of angiostatic therapy from intravital microscopy. Cancer Research.

Breier, G., Albrecht, U., Sterrer, S., and Risau, W. (1992). Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 114, 521-32.

Breier, G., Clauss, M., and Risau, W. (1995). Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development. Developmental Dynamics 204, 228-39.

Bressler, N. M., Fine, S. L., and Bressler, S. B. (1994). Angiographic interpretation of classic and occult choroidal neovascularization. In Medical and surgical retina, H. Lewis and S. J. Ryan, ed. (St. Louis: Mosby), 3-11.

Brock, T. A., Dvorak, H. F., and Senger, D. R. (1991). Tumor-secreted vascular permeability factor increases cytosolic Ca²⁺ and von Willebrand factor release in human endothelial cells. American Journal of Pathology 138, 213-21.

Brogi, E., Schatteman, G., Wu, T., Kim, E. A., Varticovski, L., Keyt, B., and Isner, J. M. (1996). Hypoxia-induced paracrine regulation of vascular endothelial growth factor receptor expression. Journal of Clinical Investigation 97, 469-76.

Brogi, E., Wu, T., Namiki, A., and Isner, J. M. (1994). Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90, 649-52.

Brooks, P. C., Montgomery, A. M., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., and Cheresh, D. A. (1994). Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157-64.

Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Guidi, A. J., Dvorak, H. F., Senger, D. R., Connolly, J. L., and Schnitt, S. J. (1995a). Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Human Pathology 26, 86-91.

Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Dvorak, H. F., and Senger, D. R. (1993a). Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. American Journal of Pathology 143, 1255-62.

Brown, L. F., Berse, B., Jackman, R. W., Tognazzi, K., Manseau, E. J., Senger, D. R., and dvorak, H. F. (1993b). Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Research 53, 4727-35.

Brown, L. F., Berse, B., Tognazzi, K., Manseau, E. J., Van de Water, L., Senger, D. R., Dvorak, H. F., and Rosen, S. (1992a). Vascular permeability factor mRNA and protein expression inhuman kidney. Kidney International 42, 1457-61.

Brown, L. F., Harrist, T. J., Yeo, K. T., Stahle-Backdahl, M., Jackman, R. W., Berse, B., Tognazzi, K., Dvorak, H. F., and Detmar, M. (1995b). Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. Journal of Investigative Dermatology 104, 744-9.

Brown, L. F., Olbricht, S. M., Berse, B., Jackman, R. W., Matsueda, G., Tognazzi, K. A., Manseau, E. J., Dvorak, H. F., and Van de Water, L. (1995c). Overexpression of vascular permeability factor (VPF/VEGF) and its endothelial cell receptors in delayed hypersensitivity skin reactions. Journal of Immunology 154, 2801-7.

Brown, L. F., Yeo, K. T., Berse, B., Yeo, T. K., Senger, D. R., Dvorak, H. F., and van deWater, L. (1992b). Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. Journal of Experimental Medicine 176, 1375-9.

Buday, L., and Downward, J. (1993). Epidermal growth factor regulates p21ras through the formation of a complex of receptor, Grb2 adapter protein, and Sos nucleotide exchange factor. Cell 73, 611-20.

Bussolino, F., Di Renzo, M. F., Ziche, M., Bocchietto, E., Olivero, M., Naldini, L., Gaudino, G., Tamagnone, L., Coffer, A., and Comoglio, P. M. (1992). Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. Journal of Cell Biology 119, 629-41.

Bär, T. (1980). The vascular system of the cerebral cortex. Advances in Anatomy, Embryology & Cell Biology 59, 1-62.

Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., and Soltoff, S. (1991). Oncogenes and signal transduction [published erratum appeared in Cell 1991May 31;65(5):following 914]. Cell 64, 281-302.

Cao, Y., Chen, H., Zhou, L., Chiang, M. K., Anand-Apte, B., Weatherbee, J. A., Wang, Y., Fang, F., Flanagan, J. G., and Tsang, M. L. (1996). Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR. Journal of Biological Chemistry 271, 3154-62.

Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W., and Nagy, A. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-9.

Carmeliet, P., Schoonjans, L., Kieckens, L., Ream, B., Degen, J., Bronson, R., De Vos, R., vanden Oord, J. J., Collen, D., and Mulligan, R. C. (1994). Physiological consequences of loss of plasminogen activator gene function in mice. Nature 368, 419-24.

Carpenter, G. (1992). Receptor tyrosine kinase substrates: src homology domains and signal transduction. FASEB Journal 6, 3283-9.

Casley-Smith, J. R. (1980). The fine structure and functioning of tissue channels and lymphatics. Lymphology 13, 177-83.

Charnock-Jones, D. S., Sharkey, A. M., Rajput-Williams, J., Burch, D., Schofield, J. P., Fountain, S. A., Boocock, C. A., and Smith, S. K. (1993). Identification and localization of alternate spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biology of Reproduction 48, 1120-8.

Choi, K., Wall, C., Hanratty, R., and Keller, G. (1994). Isolation of a gene encoding a novel receptor tyrosine kinase from differentiated embryonic stem cells. Oncogene 9, 1261-6.

Claesson-Welsh, L., Eriksson, A., Moren, A., Severinsson, L., Ek, B., Ostman, A., Betsholtz, C., and Heldin, C. H. (1988). cDNA cloning and expression of a human platelet-derived growth factor (PDGF) receptor specific for B-chain-containing PDGF molecules. Molecular & Cellular Biology 8, 3476-86.

Claffey, K. P., Senger, D. R., and Spiegelman, B. M. (1995). Structural requirements for dimerization, glycosylation, secretion, and biological function of VPF/VEGF. Biochimica et Biophysica Acta 1246, 1-9.

Claffey, K. P., Wilkison, W. O., and Spiegelman, B. M. (1992). Vascular endothelial growth factor. Regulation by cell differentiation and activated second messenger pathways. Journal of Biological Chemistry 267, 16317-22.

Clapp, C., Martial, J. A., Guzman, R. C., Rentier-Delure, F., and Weiner, R. I. (1993). the 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis. Endocrinology 133, 1292-9.

Clauss, M., Gerlach, M., Gerlach, H., Brett, J., Wang, F., Familletti, P. C., Pan, Y. C., Olander, J. V., Connolly, D. T., and Stern, D. (1990). Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. Journal of Experimental Medicine 172, 1535-45.

Coffin, J. D., Harrison, J., Schwartz, S., and Heimark, R. (1991). Angioblast differentiation and morphogenesis of the vascular endothelium in the mouse embryo. Developmental Biology 148, 51-62.

Coffin, J. D., and Poole, T. J. (1988). Embryonic vascular development: immunohistochemical identification of the origin and subsequent morphogenesis of the major vessel primordia in quail embryos. Development 102, 735-48.

Cohen, G. B., Ren, R., and Baltimore, D. (1995a). Modular binding domains in signal transduction proteins. Cell 80, 237-48.

Cohen, T., Gitay-Goren, H., Sharon, R., Shibuya, M., Halaban, R., Levi, B. Z., and Neufeld, G. (1995b). VEGF121, a vascular endothelial growth factor (VEGF) isoform lacking heparin binding ability, requires cell-surface heparan sulfates for efficient binding to the VEGF receptors of human melanoma cells. Journal of Biological Chemistry 270, 11322-6.

Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G., and Levi, B. Z. (1996). Interleukin 6induces the expression of vascular endothelial growth factor. Journal of Biological Chemistry 271, 736-41.

Conn, G., Bayne, M. L., Soderman, D. D., Kwok, P. W., Sullivan, K. A., Palisi, T. M., Hope, D. A., and Thomas, K. A. (1990). Amino acid and cDNA sequences of a vascular endothelial cell mitogen that is homologous to platelet-derived growth factor. Proceedings of the National Academy of Sciences of the United States of America 87, 2628-32.

Connolly, D. T., Heuvelman, D. M., Nelson, R., Olander, J. V., Eppley, B. L., Delfino, J. J., Siegel, N. R., Leimgruber, R. M., and Feder, J. (1989a). Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. Journal of Clinical Investigation 84, 1470-8.

Connolly, D. T., Olander, J. V., Heuvelman, D., Nelson, R., Monsell, R., Siegel, N., Haymore, B. L., Leimgruber, R., and Feder, J. (1989b). Human vascular permeability factor. Isolation from U937 cells. Journal of Biological Chemistry 264, 20017-24.

Cross, M., and Dexter, T. M. (1991). Growth factors in development, transformation, and tumorigenesis. Cell 64, 271-80.

Cullinan-Bove, K., and Koos, R. D. (1993). Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology 133, 829-37.

D'Amato, R. J., Loughnan, M. S., Flynn, E., and Folkman, J. (1994). Thalidomide is an inhibitor of angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 91, 4082-5.

D'Angelo, G., Struman, I., Martial, J., and Weiner, R. I. (1995). Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proceedings of the National Academy of Sciences of the United States of America 92, 6374-8.

Dameron, K. M., Volpert, O. V., Tainsky, M. A., and Bouck, N. (1994). Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265, 1582-4.

Davis-Smyth, T., Chen, H., Park, J., Presta, L., and Ferrara, N. (in press). The second immunoglobulin-like domain of the VEGF tyrosine kinase receptor Flt-1 determines ligand binding and may initiate a signal transduction cascade. EMBO Journal.

de Vries, C., Escobedo, J. A., Ueno, H., Houck, K., Ferrara, N., and Williams, L. T. (1992). The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255, 989-91.

Dejana, E., Corada, M., and Lampugnani, M. G. (1995). Endothelial cell-to-cell junctions. FASEB Journal 9, 910-8.

Denekamp, J. (1993). Review article: angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. British Journal of Radiology 66, 181-96.

Detmar, M., Brown, L. F., Claffey, K. P., Yeo, K. T., Kocher, O., Jackman, R. W., Berse, B., and Dvorak, H. F. (1994). Overexpression of vascular permeability factor/vascular endothelial growth factor and its receptors in psoriasis. Journal of Experimental Medicine 180, 1141-6.

DiSalvo, J., Bayne, M. L., Conn, G., Kwok, P. W., Trivedi, P. G., Soderman, D. D., Palisi, T. M., Sullivan, K. A., and Thomas, K. A. (1995). Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer. Journal of Biological Chemistry 270, 7717-23.

Dobson, D. E., Kambe, A., Block, E., Dion, T., Lu, H., Castellot, J. J., Jr., and Spiegelman, B. M. (1990). 1-Butyryl-glycerol: a novel angiogenesis factor secreted by differentiating adipocytes. Cell 61, 223-30.

Doi, K., Itoh, H., Komatsu, Y., Igaki, T., Chun, T. H., Takaya, K., Yamashita, J., Inoue, M., Yoshimasa, T., and Nakao, K. (1996). Vascular endothelial growth factor suppresses C-type natriuretic peptide secretion. Hypertension 27, 811-5.

Dougher-Vermazen, M., Hulmes, J. D., Bohlen, P., and Terman, B. I. (1994). Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor. Biochemical & Biophysical Research Communications 205, 728-38.

Drake, C. J., and Little, C. D. (1995). Exogenous vascular endothelial growth factor induces malformed and hyperfused vessels during embryonic neovascularization. Proceedings of the National Academy of Sciences of the United States of America 92, 7657-61.

Drews, R., Drohan, W. N., and Lubon, H. (1994). Transgene detection in mouse tail digests. Biotechniques 17, 866-7.

Dumont, D. J., Fong, G. H., Puri, M. C., Gradwohl, G., Alitalo, K., and Breitman, M. L. (1995). Vascularization of the mouse embryo: a study of flk-1, tek, tie, and vascular endothelial growth factor expression during development. Developmental Dynamics 203, 80-92.

Dumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A., and Breitman, M. L. (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes& Development 8, 1897-909.

Dusseau, J. W., Hutchins, P. M., and Malbasa, D. S. (1986). Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane. Circulation Research 59, 163-70.

Dvorak, H. F., Brown, L. F., Detmar, M., and Dvorak, A. M. (1995). Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. American Journal of Pathology 146, 1029-39.

Dvorak, H. F., Orenstein, N. S., Carvalho, A. C., Churchill, W. H., Dvorak, A. M., Galli, S. J., Feder, J., Bitzer, A. M., Rypysc, J., and Giovinco, P. (1979). Induction of a fibrin-gel investment: an early event in line 10 hepatocarcinoma growth mediated by tumor-secreted products. Journal of Immunology 122, 166-74.

Eichmann, A., Marcelle, C., Breant, C., and Le Douarin, N. M. (1993). Two molecules related to the VEGF receptor are expressed in early endothelial cells during avian embryonic development. Mechanisms of Development 42, 33-48.

Ekblom, P., Sariola, H., Karkinen-Jaaskelainen, M., and Saxen, L. (1982). The origin of the glomerular endothelium. Cell Differentiation 11, 35-9.

Enomoto, T., Okamoto, T., and Sato, J. D. (1994). Vascular endothelial growth factor induces the disorganization of actin stress fibers accompanied by protein tyrosine phosphorylation and morphological change in Balb/C3T3 cells. Biochemical & Biophysical Research Communications 202, 1716-23.

Evens, H. M. (1909). On the development of the aortae, cardinal and umbilical veins, and the other blood vessels of vertebrate embryos from capillaries. The Anatomical Record 3, 498-518.

Eyssen-Hernandez, R., Ladoux, A., and Frelin, C. (1996). Differential regulation of cardiac heme oxygenase-1 and vascular endothelial growth factor mRNA expression by hemin, heavy metals, heat shock and anoxia. FEBS Letters 382, 229-33.

Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., and Moore, M. W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-42.

Ferrara, N., and Henzel, W. J. (1989). Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochemical &Biophysical Research Communications 161, 851-8.

Ferrara, N., Houck, K., Jakeman, L., and Leung, D. W. (1992). Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrine Reviews 13, 18-32.

Ferrara, N., Leung, D. W., Cachianes, G., Winer, J., and Henzel, W. J. (1991). Purification and cloning of vascular endothelial growth factor secreted by pituitary folliculostellate cells. Methods in Enzymology 198, 391-405.

Fett, J. W., Strydom, D. J., Lobb, R. R., Alderman, E. M., Bethune, J. L., Riordan, J. F., and Vallee, B. L. (1985). Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 24, 5480-6.

Fiebich, B. L., Jager, B., Schollmann, C., Weindel, K., Wilting, J., Kochs, G., Marme, D., Hug, H., and Weich, H. A. (1993). Synthesis and assembly of functionally active human vascular endothelial growth factor homodimers in insect cells. European Journal of Biochemistry 211, 19-26.

Finkel, T., and Epstein, S. E. (1995). Gene therapy for vascular disease. FASEB Journal 9, 843-51.

Finkenzeller, G., Marme, D., Weich, H. A., and Hug, H. (1992). Platelet-derived growth factor-induced transcription of the vascular endothelial growth factor gene is mediated by protein kinase C. Cancer Research 52, 4821-3.

Finkenzeller, G., Technau, A., and Marme, D. (1995). Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochemical & Biophysical Research Communications 208, 432-9.

Finnerty, H., Kelleher, K., Morris, G. E., Bean, K., Merberg, D. M., Kriz, R., Morris, J. C., Sookdeo, H., Turner, K. J., and Wood, C. R. (1993). Molecular cloning of murine FLT and FLT4. Oncogene 8, 2293-8.

Fischer, S., Sharma, H. S., Karliczek, G. F., and Schaper, W. (1995). Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine. Brain Research. Molecular Brain Research 28, 141-8.

Flamme, I., Breier, G., and Risau, W. (1995a). Vascular endothelial growth factor (VEGF) and VEGF receptor 2 (flk-1) are expressed during vasculogenesis and vascular differentiation in the quail embryo. Developmental Biology 169, 699-712.

Flamme, I., von Reutern, M., Drexler, H. C., Syed-Ali, S., and Risau, W. (1995b). Overexpression of vascular endothelial growth factor in the avian embryo induces hypervascularization and increased vascular permeability without alterations of embryonic pattern formation. Developmental Biology 171, 399-414.

Folkman, J. (1971). Tumor angiogenesis: therapeutic implications. New England Journal of Medicine 285, 1182-6.

Folkman, J. (1984). What is the role of endothelial cells in angiogenesis? Laboratory Investigation 51, 601-4.

Folkman, J. (1985). Tumor angiogenesis. Advances in Cancer Research 43, 175-203.

Folkman, J. (1987). Thrombosis and haemostasis. (Leuven: Leuven University Press).

Folkman, J. (1995a). Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Medicine 1, 27-31.

Folkman, J. (1995b). Clinical applications of research on angiogenesis. New England Journal of Medicine 333, 1757-63.

Folkman, J., and Klagsbrun, M. (1987). Angiogenic factors. Science 235, 442-7.

Folkman, J., and Shing, Y. (1992). Angiogenesis. Journal of Biological Chemistry 267, 10931-4.

Folkman, J., Szabo, S., Stovroff, M., McNeil, P., Li, W., and Shing, Y. (1991). Duodenal ulcer. Discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Annals of Surgery 214, 414-25; discussion 426-7.

Folkman, J., Watson, K., Ingber, D., and Hanahan, D. (1989). Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339, 58-61.

Fong, G. H., Rossant, J., Gertsenstein, M., and Breitman, M. L. (1995). Role of the Flt-1receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-70.

Form, D. M., and Auerbach, R. (1983). PGE2 and angiogenesis. Proceedings of the Society for Experimental Biology & Medicine 172, 214-8.

Fotsis, T., Zhang, Y., Pepper, M. S., Adlercreutz, H., Montesano, R., Nawroth, P. P., and Schweigerer, L. (1994). The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth. Nature 368, 237-9.

Fournier, E., Dubreuil, P., Birnbaum, D., and Borg, J. P. (1995). Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor. Oncogene 11, 921-31.

Frank, S., Hübner, G., Breier, G., Longaker, M. T., Greenhalgh, D. G., and Werner, S. (1995). Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. Journal of Biological Chemistry 270, 12607-13.

Fraser, R. A., Ellis, E. M., and Stalker, A. L. (1979). Experimental angiogenesis in the chorio-allantoic membrane. Bibliotheca Anatomica 25-7.

Fràter-Schröder, M., Risau, W., Hallmann, R., Gautschi, P., and Bohlen, P. (1987). Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proceedings of the National Academy of Sciences of the United States of America 84, 5277-81.

Freeman, M. R., Schneck, F. X., Gagnon, M. L., Corless, C., Soker, S., Niknejad, K., Peoples, G. E., and Klagsbrun, M. (1995). Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: a potential role for T cells in angiogenesis. Cancer Research 55, 4140-5.

Furie, B., and Furie, B. C. (1988). The molecular basis of blood coagulation. Cell 53, 505-18.

Galland, F., Karamysheva, A., Mattei, M. G., Rosnet, O., Marchetto, S., and Birnbaum, D. (1992). Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene. Genomics 13, 475-8.

Galland, F., Karamysheva, A., Pebusque, M. J., Borg, J. P., Rottapel, R., Dubreuil, P., Rosnet, O., and Birnbaum, D. (1993). The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor. Oncogene 8, 1233-40.

Garrido, C., Saule, S., and Gospodarowicz, D. (1993). Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells. Growth Factors 8, 109-17.

Geneser, F. (1986). The circulatory system. In Textbook of Histology, (Odense: Munksgaard),333-362.

Germain, L., Blouin, M. J., and Marceau, N. (1988). Biliary epithelial and hepatocytic cell lineage relationships in embryonic rat liver as determined by the differential expression of cytokeratins, alpha-fetoprotein, albumin, and cell surface-exposed components. Cancer Research 48, 4909-18.

Giese, N., May-Siroff, M., LaRochelle, W. J., van Wyke Coelingh, K., and Aaronson, S. A. (1989). Expression and purification of biologically active v-sis/platelet-derived growth factor B protein by using a baculovirus vector system. Journal of Virology 63, 3080-6.

Gilbert, S. F. (1991). Heart and circulatory system. In Developmental Biology, (Sunderland: Sinauer), 219.

Gimbrone, M. A., Jr., Leapman, S. B., Cotran, R. S., and Folkman, J. (1972). Tumor dormancy in vivo by prevention of neovascularization. Journal of Experimental Medicine 136, 261-76.

Gitay-Goren, H., Soker, S., Vlodavsky, I., and Neufeld, G. (1992). The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. Journal of Biological Chemistry 267, 6093-8.

Gleadle, J. M., Ebert, B. L., Firth, J. D., and Ratcliffe, P. J. (1995). Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents. American Journal of Physiology 268, C1362-8.

Goldberg, M. A., and Schneider, T. J. (1994). Similarities between the oxygen-sensing mechanisms regulating the expression of vascular endothelial growth factor and erythropoietin. Journal of Biological Chemistry 269, 4355-9.

Goldman, C. K., Kim, J., Wong, W. L., King, V., Brock, T., and Gillespie, G. Y. (1993). Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology. Molecular Biology of the Cell 4, 121-33.

Gospodarowicz, D., Abraham, J. A., and Schilling, J. (1989). Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proceedings of the National Academy of Sciences of the United States of America 86, 7311-5.

Gospodarowicz, D., Bialecki, H., and Thakral, T. K. (1979). The angiogenic activity of the fibroblast and epidermal growth factor. Experimental Eye Research 28, 501-14.

Goto, F., Goto, K., Weindel, K., and Folkman, J. (1993). Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Laboratory Investigation 69, 508-17.

Graeber, J. E., Glaser, B. M., Setty, B. N., Jerdan, J. A., Walenga, R. W., and Stuart, M. J. (1990). 15-Hydroxyeicosatetraenoic acid stimulates migration of human retinal microvessel endothelium in vitro and neovascularization in vivo. Prostaglandins 39, 665-73.

Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., and Giaccia, A. J. (1996). Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature 379, 88-91.

Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L., Polverini, P., and Rosen, E. M. (1993a). Scatter factor induces blood vessel formation in vivo. Proceedings of the National Academy of Sciences of the United States of America 90, 1937-41.

Grant, D. S., Kleinman, H. K., and Martin, G. R. (1990). The role of basement membranes in vascular development. Annals of the New York Academy of Sciences 588, 61-72.

Grant, M. B., Caballero, S., and Millard, W. J. (1993b). Inhibition of IGF-I and b-FGF stimulated growth of human retinal endothelial cells by the somatostatin analogue, octreotide: a potential treatment for ocular neovascularization. Regulatory Peptides 48, 267-78.

Grant, M. B., Mames, R. N., Fitzgerald, C., Ellis, E. A., Aboufriekha, M., and Guy, J. (1993c). Insulin-like growth factor I acts as an angiogenic agent in rabbit cornea and retina:comparative studies with basic fibroblast growth factor. Diabetologia 36, 282-91.

Grimmond, S., Lagercrantz, J., Drinkwater, C., Silins, G., Townson, S., Pollock, P., Gotley, D., Carson, E., Rakar, S., Nordenskjöld, M., Ward, L., Hayward, N., and Weber, G. (1996). Cloning and characterization of a novel human gene related to vascular endothelial growth factor. Genome Research 6, 124-131.

Grosskreutz, C. L., Anand-Apte, B., Terman, B., Quinn, T. P., and D´Amore, P. A. (1996). Vascular endothelial growth factor (VEGF) is a chemoattractant for vascular smooth muscle cells (SMC). Investigative Ophthalmology & Visual Science 37, 5470-.

Gruber, B. L., Marchese, M. J., and Kew, R. (1995). Angiogenic factors stimulate mast-cell migration. Blood 86, 2488-93.

Guerrin, M., Moukadiri, H., Chollet, P., Moro, F., Dutt, K., Malecaze, F., and Plouët, J. (1995). Vasculotropin/vascular endothelial growth factor is an autocrine growth factor for human retinal pigment epithelial cells cultured in vitro. Journal of Cellular Physiology 164, 385-94.

Guidi, A. J., Abu-Jawdeh, G., Berse, B., Jackman, R. W., Tognazzi, K., Dvorak, H. F., and Brown, L. F. (1995). Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in cervical neoplasia. Journal of the National Cancer Institute 87, 1237-45.

Gulick, J., Subramaniam, A., Neumann, J., and Robbins, J. (1991). Isolation and characterization of the mouse cardiac myosin heavy chain genes. Journal of Biological Chemistry 266, 9180-5.

Guo, D., Jia, Q., Song, H. Y., Warren, R. S., and Donner, D. B. (1995). Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. Journal of Biological Chemistry 270, 6729-33.

Guo, L., Yu, Q. C., and Fuchs, E. (1993). Targeting expression of keratinocyte growth factor to keratinocytes elicits striking changes in epithelial differentiation in transgenic mice. EMBO Journal 12, 973-86.

Gupta, S. K., Hassel, T., and Singh, J. P. (1995). A potent inhibitor of endothelial cell proliferation is generated by proteolytic cleavage of the chemokine platelet factor 4. Proceedings of the National Academy of Sciences of the United States of America 92, 7799-803.

Hanahan, D. (1985). Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 315, 115-22.

Hanahan, D., and Folkman, J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-64.

Hanneken, A., Ying, W., Ling, N., and Baird, A. (1994). Identification of soluble forms of the fibroblast growth factor receptor in blood. Proceedings of the National Academy of Sciences of the United States of America 91, 9170-4.

Harada, S., Rodan, S. B., and Rodan, G. A. (1995). Expression and regulation of vascular endothelial growth factor in osteoblasts. Clinical Orthopaedics & Related Research 313, 76-80.

Hashimoto, E., Kage, K., Ogita, T., Nakaoka, T., Matsuoka, R., and Kira, Y. (1994). Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA in U-937 cells. Biochemical & Biophysical Research Communications 204, 318-24.

Hashimoto, M., Ohsawa, M., Ohnishi, A., Naka, N., Hirota, S., Kitamura, Y., and Aozasa, K. (1995). Expression of vascular endothelial growth factor and its receptor mRNA in angiosarcoma. Laboratory Investigation 73, 859-63.

Haslam, R. J., Koide, H. B., and Hemmings, B. A. (1993). Pleckstrin domain homology [letter]. Nature 363, 309-10.

Hatva, E., Kaipainen, A., Mentula, P., Jaaskelainen, J., Paetau, A., Haltia, M., and Alitalo, K. (1995). Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. American Journal of Pathology 146, 368-78.

Hauser, S., and Weich, H. A. (1993). A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta. Growth Factors 9, 259-68.

His, W. (1900). Lecithoblast und Angioblast der Wirbelthiere. Akademie der Wissenschaften 22, 171-328.

Hogan, B., Beddington, R., Costantini, F., and Lacy, E. (1994). Manipulating the mouse embryo. A laboratory manual. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).

Holmgren, L., O'Reilly, M. S., and Folkman, J. (1995). Dormancy of micrometastases:balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nature Medicine 1, 149-53.

Homandberg, G. A., Williams, J. E., Grant, D., Schumacher, B., and Eisenstein, R. (1985). Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth. American Journal of Pathology 120, 327-32.

Honegger, A. M., Schmidt, A., Ullrich, A., and Schlessinger, J. (1990). Evidence for epidermal growth factor (EGF)-induced intermolecular autophosphorylation of the EGF receptors in living cells. Molecular & Cellular Biology 10, 4035-44.

Houck, K. A., Ferrara, N., Winer, J., Cachianes, G., Li, B., and Leung, D. W. (1991). The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Molecular Endocrinology 5, 1806-14.

Houck, K. A., Leung, D. W., Rowland, A. M., Winer, J., and Ferrara, N. (1992). Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. Journal of Biological Chemistry 267, 26031-7.

Hu, P., Margolis, B., Skolnik, E. Y., Lammers, R., Ullrich, A., and Schlessinger, J. (1992). Interaction of phosphatidylinositol 3-kinase-associated p85 with epidermal growth factor and platelet-derived growth factor receptors. Molecular & Cellular Biology 12, 981-90.

Hudgins, W. R., Hampton, B., Burgess, W. H., and Perdue, J. F. (1992). The identification of O-glycosylated precursors of insulin-like growth factor II. Journal of Biological Chemistry 267, 8153-60.

Ikeda, E., Achen, M. G., Breier, G., and Risau, W. (1995). Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. Journal of Biological Chemistry 270, 19761-6.

Ingber, D., Fujita, T., Kishimoto, S., Sudo, K., Kanamaru, T., Brem, H., and Folkman, J. (1990). Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348, 555-7.

Iruela-Arispe, M. L., Bornstein, P., and Sage, H. (1991). Thrombospondin exerts anantiangiogenic effect on cord formation by endothelial cells in vitro. Proceedings of the National Academy of Sciences of the United States of America 88, 5026-30.

Ishikawa, F., Miyazono, K., Hellman, U., Drexler, H., Wernstedt, C., Hagiwara, K., Usuki, K., Takaku, F., Risau, W., and Heldin, C. H. (1989). Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338, 557-62.

Isner, J. M., Pieczek, A., Schainfeld, R., Blair, R., Haley, L., Asahara, T., Rosenfield, K., Razvi, S., Walsh, K., and Symes, J. F. (1996). Clinical evidence of angiogenesis following arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet 348, 370-74.

Jackson, D., Volpert, O. V., Bouck, N., and Linzer, D. I. (1994). Stimulation and inhibition of angiogenesis by placental proliferin and proliferin-related protein. Science 266, 1581-4.

Jakeman, L. B., Armanini, M., Phillips, H. S., and Ferrara, N. (1993). Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 133, 848-59.

Jakeman, L. B., Winer, J., Bennett, G. L., Altar, C. A., and Ferrara, N. (1992). Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues. Journal of Clinical Investigation 89, 244-53.

Johnson, M. D., Kim, H. R., Chesler, L., Tsao-Wu, G., Bouck, N., and Polverini, P. J. (1994). Inhibition of angiogenesis by tissue inhibitor of metalloproteinase. Journal of Cellular Physiology 160, 194-202.

Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., and Alitalo, K. (1996). A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases [published erratum appeared in EMBO J 1996 Apr 1;15(7):1751]. EMBO Journal 15, 290-98.

Kaipainen, A., Korhonen, J., Mustonen, T., van Hinsbergh, V. W., Fang, G. H., Dumont, D., Breitman, M., and Alitalo, K. (1995). Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proceedings of the National Academy of Sciences of the United States of America 92, 3566-70.

Kaipainen, A., Korhonen, J., Pajusola, K., Aprelikova, O., Persico, M. G., Terman, B. I., and Alitalo, K. (1993). The related FLT4, FLT1, and KDR receptor tyrosine kinases show distinct expression patterns in human fetal endothelial cells. Journal of Experimental Medicine 178, 2077-88.

Kandel, J., Bossy-Wetzel, E., Radvanyi, F., Klagsbrun, M., Folkman, J., and Hanahan, D. (1991). Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66, 1095-104.

Karnovsky, M. L., Graham, R., Karnovsky, M. J., Saito, K., Shafer, A. W., and Glass, E. (1967). Phagocytosis and related phenomena. Protoplasma 63, 88-9.

Karunagaran, D., Tzahar, E., Beerli, R. R., Chen, X., Graus-Porta, D., Ratzkin, B. J., Seger, R., Hynes, N. E., and Yarden, Y. (1996). ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO Journal 15, 254-64.

Keck, P. J., Hauser, S. D., Krivi, G., Sanzo, K., Warren, T., Feder, J., and Connolly, D. T. (1989). Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 246, 1309-12.

Kendall, R. L., and Thomas, K. A. (1993). Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proceedings of the National Academy of Sciences of the United States of America 90, 10705-9.

Kenney, W. C., Haniu, M., Herman, A. C., Arakawa, T., Costigan, V. J., Lary, J., Yphantis, D. A., and Thomason, A. R. (1994). Formation of mitogenically active PDGF-B dimer does not require interchain disulfide bonds. Journal of Biological Chemistry 269, 12351-9.

Keyt, B., Berleau, L., Nguyen, H., Heinshon, H., Chen, H., Vandlen, R., and Ferrara, N. (1996). The carboxyl-terminal domain (111-165) of VEGF is critical for mitogenic potency. Journal of Biological Chemistry 271, 7788-95.

Kieser, A., Weich, H. A., Brandner, G., Marme, D., and Kolch, W. (1994). Mutant P53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9, 963-9.

Kim, K. J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H. S., and Ferrara, N. (1993). Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-4.

Kinzler, K. W., and Vogelstein, B. (1996). Life (and death) in a malignant tumour [news;comment]. Nature 379, 19-20.

Klagsbrun, M., and D'Amore, P. A. (1991). Regulators of angiogenesis. Annual Review of Physiology 53, 217-239.

Klagsbrun, M., and D'Amore, P. A. (in press). Vascular endothelial growth factor and its receptors. Cytokine & Growth Factor Reviews.

Koch, A. E., Harlow, L. A., Haines, G. K., Amento, E. P., Unemori, E. N., Wong, W. L., Pope, R. M., and Ferrara, N. (1994). Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis. Journal of Immunology 152, 4149-56.

Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. (1992). Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258, 1798-801.

Koch, C. A., Anderson, D., Moran, M. F., Ellis, C., and Pawson, T. (1991). SH2 and SH3 domains: elements that control interactions of cytoplasmic signaling proteins. Science 252, 668-74.

Kohn, S., Nagy, J. A., Dvorak, H. F., and Dvorak, A. M. (1992). Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Laboratory Investigation 67, 596-607.

Kondo, S., Matsumoto, T., Yokoyama, Y., Ohmori, I., and Suzuki, H. (1995). The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability. Biochimica et Biophysica Acta 1243, 195-202.

Koolwijk, P., van Erck, M. G., de Vree, W. J., Vermeer, M. A., Weich, H. A., Hanemaaijer, R., and van Hinsbergh, V. W. (1996). Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. Journal of Cell Biology 132, 1177-88.

Ku, D. D., Zaleski, J. K., Liu, S., and Brock, T. A. (1993). Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. American Journal of Physiology 265, H586-92.

Kubota, Y., Kleinman, H. K., Martin, G. R., and Lawley, T. J. (1988). Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. Journal of Cell Biology 107, 1589-98.

Kukk, E., Lymboussaki, A., Taira, S., Kaipainen, A., Jeltsch, M., Joukov, V., and Alitalo, K. (in press). VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular development. Development.

Kull, F. C., Jr., Brent, D. A., Parikh, I., and Cuatrecasas, P. (1987). Chemical identification of a tumor-derived angiogenic factor. Science 236, 843-5.

Ladoux, A., and Frelin, C. (1993). Hypoxia is a strong inducer of vascular endothelial growth factor mRNA expression in the heart. Biochemical & Biophysical Research Communications 195, 1005-10.

Lagercrantz, J., Larsson, C., Grimmond, S., Fredriksson, M., Weber, G., and Piehl, F. (1996). Expression of the VEGF-related factor gene in pre- and postnatal mouse. Biochemical& Biophysical Research Communications 220, 147-52.

Laird, P. W., Zijderveld, A., Linders, K., Rudnicki, M. A., Jaenisch, R., and Berns, A. (1991). Simplified mammalian DNA isolation procedure. Nucleic Acids Research 19, 4293.

Lane, T. F., Iruela-Arispe, M. L., Johnson, R. S., and Sage, E. H. (1994). SPARC is a source of copper-binding peptides that stimulate angiogenesis. Journal of Cell Biology 125, 929-43.

Leak, L. V. (1970). Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissue-lymph interface. Microvascular Research 2, 361-91.

Lee, J., Gray, A., Yuan, J., Luoh, S.-M., Avraham, H., and Wood, W. I. (1996). Vascular endothelial growth factor-related protein: A ligand and specific activator of the Tyrosine kinase receptor Flt4. Proceedings of the National Academy of Sciences of the United States of America 93, 1988-1992.

Lee, K. (1980). Surgery of cysts and tumors of the neck. In Otolaryngology, M. Paparellaand, D. Shunrick, ed. (Philadelphia: Saunders), 2987.

Leibovich, S. J., Polverini, P. J., Shepard, H. M., Wiseman, D. M., Shively, V., and Nuseir, N. (1987). Macrophage-induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 329, 630-2.

Lemmon, M. A., and Schlessinger, J. (1994). Regulation of signal transduction and signal diversity by receptor oligomerization. Trends in Biochemical Sciences 19, 459-63.

Leung, D. W., Cachianes, G., Kuang, W. J., Goeddel, D. V., and Ferrara, N. (1989). Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246, 1306-9.

Levy, A. P., Levy, N. S., Wegner, S., and Goldberg, M. A. (1995). Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. Journal of Biological Chemistry 270, 13333-40.

Li, J., Perrella, M. A., Tsai, J. C., Yet, S. F., Hsieh, C. M., Yoshizumi, M., Patterson, C., Endege, W. O., Zhou, F., and Lee, M. E. (1995). Induction of vascular endothelial growth factor gene expression by interleukin-1 beta in rat aortic smooth muscle cells. Journal of Biological Chemistry 270, 308-12.

Li, V. W., Folkerth, R. D., Watanabe, H., Yu, C., Rupnick, M., Barnes, P., Scott, R. M., Black, P. M., Sallan, S. E., and Folkman, J. (1994). Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344, 82-6.

Linask, K. K., and Lash, J. W. (1986). Precardiac cell migration: fibronectin localization at mesoderm-endoderm interface during directional movement. Developmental Biology 114, 87-101.

Liotta, L. A., Kleinerman, J., and Saidel, G. M. (1974). Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Research 34, 997-1004.

Liotta, L. A., Steeg, P. S., and Stetler-Stevenson, W. G. (1991). Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64, 327-36.

Liu, Y., Cox, S. R., Morita, T., and Kourembanas, S. (1995). Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer. Circulation Research 77, 638-43.

Lobb, R. R., Alderman, E. M., and Fett, J. W. (1985). Induction of angiogenesis by bovine brain derived class 1 heparin-binding growth factor. Biochemistry 24, 4969-73.

Lu, H. S., Hara, S., Wong, L. W., Jones, M. D., Katta, V., Trail, G., Zou, A., Brankow, D., Cole, S., Hu, S., and et al. (1995). Post-translational processing of membrane-associated neu differentiation factor proisoforms expressed in mammalian cells. Journal of Biological Chemistry 270, 4775-83.

Luckow, V. A., Lee, S. C., Barry, G. F., and Olins, P. O. (1993). Efficient generation of infectious recombinant baculoviruses by site-specific transposon-mediated insertion of foreign genes into a baculovirus genome propagated in Escherichia coli. Journal of Virology 67, 4566-79.

Lyttle, D. J., Fraser, K. M., Fleming, S. B., Mercer, A. A., and Robinson, A. J. (1994). Homologs of vascular endothelial growth factor are encoded by the poxvirus orf virus. Journal of Virology 68, 84-92.

Maglione, D., Guerriero, V., Viglietto, G., Delli-Bovi, P., and Persico, M. G. (1991). Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proceedings of the National Academy of Sciences of the United States of America 88, 9267-71.

Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O., Alitalo, K., DelVecchio, S., Lei, K. J., Chou, J. Y., and Persico, M. G. (1993). Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14. Oncogene 8, 925-31.

Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F., and Sharpe, R. J. (1990). Inhibition of angiogenesis by recombinant human platelet factor-4and related peptides. Science 247, 77-9.

Malecaze, F., Clamens, S., Simorre-Pinatel, V., Mathis, A., Chollet, P., Favard, C., Bayard, F., and Plouët, J. (1994). Detection of vascular endothelial growth factor messenger RNA and vascular endothelial growth factor-like activity in proliferative diabetic retinopathy. Archives of Ophthalmology 112, 1476-82.

Mall, G., Zimmer, G., Baden, S., and Mattfeldt, T. (1990). Capillary neoformation in the rat heart - stereological studies on papillary muscles in hypertrophy and physiologic growth. Basic Research in Cardiology 85, 531-40.

Mandriotta, S. J., Seghezzi, G., Vassalli, J.-D., Ferrara, N., Wasi, S., Mazzieri, R., Mignatti, P., and Pepper, M. S. (1995). Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells. Journal of Biological Chemistry 270, 9709-9716.

Maragoudakis, M. E., Sarmonika, M., and Panoutsacopoulou, M. (1988). Inhibition of basement membrane biosynthesis prevents angiogenesis. Journal of Pharmacology & Experimental Therapeutics 244, 729-33.

Masferrer, J. L., Rimarachin, J. A., Gerritsen, M. E., Falck, J. R., Yadagiri, P., Dunn, M. W., and Laniado-Schwartzman, M. (1991). 12(R)-hydroxyeicosatrienoic acid, a potent chemotactic and angiogenic factor produced by the cornea. Experimental Eye Research 52, 417-24.

Mattern, J., Koomagi, R., and Volm, M. (1996). Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. British Journal of Cancer 73, 931-4.

Matthews, W., Jordan, C. T., Gavin, M., Jenkins, N. A., Copeland, N. G., and Lemischka, I. R. (1991). A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proceedings of the National Academy of Sciences of the United States of America 88, 9026-30.

McDonald, N. Q., and Hendrickson, W. A. (1993). A structural superfamily of growth factors containing a cystine knot motif. Cell 73, 421-4.

Michaelson, I. C. (1948). The mode of development of the vascular system of the retina with some observations on its significance for certain retinal disorders. Transactions of the Ophthalmological Societies of the United Kingdom 68, 137-80.

Midy, V., and Plouët, J. (1994). Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochemical & Biophysical Research Communications 199, 380-6.

Millauer, B., Shawver, L. K., Plate, K. H., Risau, W., and Ullrich, A. (1994). Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367, 576-9.

Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W., and Ullrich, A. (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-46.

Miller, L. K. (1988). Baculoviruses as gene expression vectors. Annual Review of Microbiology 42, 177-99.

Min, H. Y., Doyle, L. V., Vitt, C. R., Zandonella, C. L., Stratton-Thomas, J. R., Shuman, M. A., and Rosenberg, S. (1996). Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice. Cancer Research 56, 2428-33.

Minchenko, A., Bauer, T., Salceda, S., and Caro, J. (1994). Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo. Laboratory Investigation 71, 374-9.

Modlich, U., Kaup, F. J., and Augustin, H. G. (1996). Cyclic angiogenesis and blood vessel regression in the ovary: blood vessel regression during luteolysis involves endothelial cell detachment and vessel occlusion. Laboratory Investigation 74, 771-80.

Moghaddam, A., and Bicknell, R. (1992). Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. Biochemistry 31, 12141-6.

Montesano, R., Vassalli, J. D., Baird, A., Guillemin, R., and Orci, L. (1986). Basic fibroblast growth factor induces angiogenesis in vitro. Proceedings of the National Academy of Sciences of the United States of America 83, 7297-301.

Montrucchio, G., Lupia, E., Battaglia, E., Passerini, G., Bussolino, F., Emanuelli, G., and Camussi, G. (1994). Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis. Journal of Experimental Medicine 180, 377-82.

Morishita, K., Johnson, D. E., and Williams, L. T. (1995). A novel promoter for vascular endothelial growth factor receptor (flt-1) that confers endothelial-specific gene expression. Journal of Biological Chemistry 270, 27948-53.

Morris, S. W., Kirstein, M. N., Valentine, M. B., Dittmer, K. G., Shapiro, D. N., Saltman, D. L., and Look, A. T. (1994). Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, ni non-Hodgkin's lymphoma [published erratum appeared in Science 1995 Jan 20;267(5196):316-7]. Science 263, 1281-4.

Moscatelli, D., and Rifkin, D. B. (1988). Membrane and matrix localization of proteinases:a common theme in tumor cell invasion and angiogenesis. Biochimica et Biophysica Acta 948, 67-85.

Moses, M. A. (1993). A cartilage-derived inhibitor of neovascularization and metalloproteinases. Clinical & Experimental Rheumatology 11, S67-9.

Mukhopadhyay, D., Tsiokas, L., Zhou, X. M., Foster, D., Brugge, J. S., and Sukhatme, V. P. (1995). Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 375, 577-81.

Müller, G., Behrens, J., Nussbaumer, U., Böhlen, P., and Birchmeier, W. (1987). Inhibitory action of transforming growth factor beta on endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 84, 5600-4.

Murphy, A. N., Unsworth, E. J., and Stetler-Stevenson, W. G. (1993). Tissue inhibitor of metalloproteinases-2 inhibits bFGF-induced human microvascular endothelial cell proliferation. Journal of Cellular Physiology 157, 351-8.

Mustonen, T., and Alitalo, K. (1995). Endothelial receptor tyrosine kinases involved in angiogenesis. Journal of Cell Biology 129, 895-8.

Myoken, Y., Kayada, Y., Okamoto, T., Kan, M., Sato, G. H., and Sato, J. D. (1991). Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites. Proceedings of the National Academy of Sciences of the United States of America 88, 5819-23.

Nelson, J., Allen, W. E., Scott, W. N., Bailie, J. R., Walker, B., McFerran, N. V., and Wilson, D. J. (1995). Murine epidermal growth factor (EGF) fragment (33-42) inhibits both EGF- and laminin-dependent endothelial cell motility and angiogenesis. Cancer Research 55, 3772-6.

Nelson, W. G., and Sun, T. T. (1983). The 50- and 58-kdalton keratin classes as molecular markers for stratified squamous epithelia: cell culture studies. Journal of Cell Biology 97, 244-51.

Nguyen, M., Watanabe, H., Budson, A. E., Richie, J. P., Hayes, D. F., and Folkman, J. (1994). Elevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancers. Journal of the National Cancer Institute 86, 356-61.

Nguyen, N. M., Lehr, J. E., and Pienta, K. J. (1993). Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo. Anticancer Research 13, 2143-7.

Nicola, N. A. (1994). Guidebook to Cytokines and Their Receptors. New York: Sambrook and Tooze Publications.

Nomura, M., Yamagishi, S., Harada, S., Hayashi, Y., Yamashima, T., Yamashita, J., and Yamamoto, H. (1995). Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. Journal of Biological Chemistry 270, 28316-24.

O'Reilly, D. R., Miller, L. K., and Luckow, V. A. (1992). Baculovirus expression vectors: A laboratory manual. (New York: W. H. Freeman and Company).

O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. (1994). Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-28.

Oefner, C., D'Arcy, A., Winkler, F. K., Eggimann, B., and Hosang, M. (1992). Crystal structure of human platelet-derived growth factor BB. EMBO Journal 11, 3921-6.

Oelrichs, R. B., Reid, H. H., Bernard, O., Ziemiecki, A., and Wilks, A. F. (1993). NYK/FLK-1: a putative receptor protein tyrosine kinase isolated from E10 embryonic neuroepithelium is expressed in endothelial cells of the developing embryo. Oncogene 8, 11-8.

Oh, S.-J., Birkenhäger, R., McCarthy, J. E. G., Weich, H. A., Christ, B., and Wilting, J. (submitted). The lymphatics of the avian chorioallantoic membrane: differential reactivity of blood vascular and lymphatic endothelium to endothelial growth factors.

Oikawa, T., Okayasu, I., Ashino, H., Morita, I., Murota, S., and Shudo, K. (1993). Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo. European Journal of Pharmacology 249, 113-6.

Oikawa, T., Suganuma, M., Ashino-Fuse, H., and Shimamura, M. (1992). Okadaic acid is a potent angiogenesis inducer. Japanese Journal of Cancer Research 83, 6-9.

Olander, J. V., Connolly, D. T., and DeLarco, J. E. (1991). Specific binding of vascular permeability factor to endothelial cells. Biochemical & Biophysical Research Communications 175, 68-76.

Oliver, S. J., Banquerigo, M. L., and Brahn, E. (1994). Suppression of collagen-induced arthritis using an angiogenesis inhibitor, AGM-1470, and a microtubule stabilizer, taxol. Cellular Immunology 157, 291-9.

Olk, R. J., and Lee, C. M. (1993). Diabetic retinopathy: practical management.(Philadelphia: Lippincott & Co.).

Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V., Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K., and Eriksson, U. (1996a). Vascular endothelial growth factor B, a novel growth factor for endothelial cells. Proceedings of the National Academy of Sciences of the United States of America 93, 2576-81.

Olofsson, B., Pajusola, K., von Euler, G., Chilov, D., Alitalo, K., and Eriksson, U. (1996b). Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform. Journal of Biological Chemistry 271, 19310-19317.

Olson, T. A., Mohanraj, D., Carson, L. F., and Ramakrishnan, S. (1994). Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Research 54, 276-80.

Omura, T., Östman, A., and Heldin, C.-H. (1997). Identification of a 190 kDa VEGF165 cell surface binding protein on a human glioma cell line. Journal of Biological Chemistry 272, 23317-22

Paavonen, K., Horelli-Kuitunen, N., Chilov, D., Kukk, E., Pennanen, S., Kallioniemi, O.-P., Pajusola, K., Olofsson, B., Eriksson, U., Joukov, V., Palotie, A., and Alitalo, K. (1996). Novel human vascular endothelial growth factor genes VEGF-B and VEGF-C localize to chromosomes 11q13 and 4q34, respectively. Circulation 93, 1079-82.

Pajusola, K. (1996). Cloning and characterization of a new endothelial receptor tyrosine kinase Flt4 and two novel VEGF-like growth factors VEGF-B and VEGF-C. Academic Dissertation, Helsinki: University of Helsinki.

Pajusola, K., Aprelikova, O., Armstrong, E., Morris, S., and Alitalo, K. (1993). Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. Oncogene 8, 2931-7.

Pajusola, K., Aprelikova, O., Korhonen, J., Kaipainen, A., Pertovaara, L., Alitalo, R., and Alitalo, K. (1992). FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines [published erratum appeared in Cancer Res 1993 Aug 15;53(16):3845]. Cancer Research 52, 5738-43.

Pajusola, K., Aprelikova, O., Pelicci, G., Weich, H., Claesson-Welsh, L., and Alitalo, K. (1994). Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors. Oncogene 9, 3545-55.

Parangi, S., Dietrich, W., Christofori, G., Lander, E. S., and Hanahan, D. (1995). Tumor suppressor loci on mouse chromosomes 9 and 16 are lost at distinct stages of tumorigenesis in a transgenic model of islet cell carcinoma. Cancer Research 55, 6071-6.

Pardanaud, L., Altmann, C., Kitos, P., Dieterlen-Lievre, F., and Buck, C. A. (1987). Vasculogenesis in the early quail blastodisc as studied with a monoclonal antibody recognizing endothelial cells. Development 100, 339-49.

Pardanaud, L., Yassine, F., and Dieterlen-Lievre, F. (1989). Relationship between vasculogenesis, angiogenesis and haemopoiesis during avian ontogeny. Development 105, 473-85.

Park, J. E., Chen, H. H., Winer, J., Houck, K. A., and Ferrara, N. (1994). Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. Journal of Biological Chemistry 269, 25646-54.

Park, J. E., Keller, G. A., and Ferrara, N. (1993). The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Molecular Biology of the Cell 4, 1317-26.

Pawson, T. (1995). Protein modules and signalling networks. Nature 373, 573-80.

Pekala, P., Marlow, M., Heuvelman, D., and Connolly, D. (1990). Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. Journal of Biological Chemistry 265, 18051-4.

Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. (1991). Vascular endothelial growthfactor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochemical & Biophysical Research Communications 181, 902-6.

Pepper, M. S., Ferrara, N., Orci, L., and Montesano, R. (1992). Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochemical & Biophysical Research Communications 189, 824-31.

Pepper, M. S., Vassalli, J. D., Orci, L., and Montesano, R. (1993). Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Experimental Cell Research 204, 356-63.

Pepper, M. S., Wasi, S., Ferrara, N., Orci, L., and Montesano, R. (1994). In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells. Experimental Cell Research 210, 298-305.

Pertovaara, L., Kaipainen, A., Mustonen, T., Orpana, A., Ferrara, N., Saksela, O., and Alitalo, K. (1994). Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells. Journal of Biological Chemistry 269, 6271-4.

Pertovaara, L., Saksela, O., and Alitalo, K. (1993). Enhanced bFGF gene expression in response to transforming growth factor-beta stimulation of AKR-2B cells. Growth Factors 9, 81-6.

Peters, K. G., De Vries, C., and Williams, L. T. (1993). Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proceedings of the National Academy of Sciences of the United States of America 90, 8915-9.

Philips, H. E. (1981). Intrauterine fetal cystic hygromata: sonographic detection. American Journal of Roentgenology 136, 799-802.

Phillips, G. D., Stone, A. M., Jones, B. D., Schultz, J. C., Whitehead, R. A., and Knighton, D. R. (1994). Vascular endothelial growth factor (rhVEGF165) stimulates direct angiogenesis in the rabbit cornea. In Vivo 8, 961-5.

Phillips, H. S., Hains, J., Leung, D. W., and Ferrara, N. (1990). Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 127, 965-7.

Pierce, E. A., Avery, R. L., Foley, E. D., Aiello, L. P., and Smith, L. E. (1995). Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proceedings of the National Academy of Sciences of the United States of America 92, 905-9.

Pitcher, J. A., Touhara, K., Payne, E. S., and Lefkowitz, R. J. (1995). Pleckstrin homology domain-mediated membrane association and activation of the beta-adrenergic receptor kinase requires coordinate interaction with G beta gamma subunits and lipid. Journal of Biological Chemistry 270, 11707-10.

Plate, K. H., Breier, G., Weich, H. A., and Risau, W. (1992). Vascular endothelial growthfactor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359, 845-8.

Plouët, J., and Moukadiri, H. (1990). Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. Journal of Biological Chemistry 265, 22071-4.

Plouët, J., Schilling, J., and Gospodarowicz, D. (1989). Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO Journal 8, 3801-6.

Plow, E. F., Herren, T., Redlitz, A., Miles, L. A., and Hoover-Plow, J. L. (1995). The cell biology of the plasminogen system. FASEB Journal 9, 939-45.

Przyklenk, K., and Groom, A. C. (1985). Effects of exercise frequency, intensity, and duration on revascularization in the transition zone of infarcted rat hearts. Canadian Journal of Physiology & Pharmacology 63, 273-8.

Puri, M. C., Rossant, J., Alitalo, K., Bernstein, A., and Partanen, J. (1995). The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO Journal 14, 5884-5891.

Pötgens, A. J., Lubsen, N. H., van Altena, M. C., Vermeulen, R., Bakker, A., Schoenmakers, J. G., Ruiter, D. J., and de Waal, R. M. (1994). Covalent dimerization of vascular permeability factor/vascular endothelial growth factor is essential for its biological activity. Evidence from Cys to Ser mutations. Journal of Biological Chemistry 269, 32879-85.

Qu, H., Nagy, J. A., Senger, D. R., Dvorak, H. F., and Dvorak, A. M. (1995). Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelial. Journal of Histochemistry & Cytochemistry 43, 381-9.

Quinn, T. P., Peters, K. G., De Vries, C., Ferrara, N., and Williams, L. T. (1993). Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proceedings of the National Academy of Sciences of the United States of America 90, 7533-7.

Raju, K. S., Alessandri, G., and Gullino, P. M. (1984). Characterization of a chemoattractant for endothelium induced by angiogenesis effectors. Cancer Research 44, 1579-84.

Rak, J., Mitsuhashi, Y., Bayko, L., Filmus, J., Shirasawa, S., Sasazuki, T., and Kerbel, R. S. (1995). Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Research 55, 4575-80.

Rastinejad, F., Polverini, P. J., and Bouck, N. P. (1989). Regulation of the activity of anew inhibitor of angiogenesis by a cancer suppressor gene. Cell 56, 345-55.

Reynolds, L. P., Killilea, S. D., and Redmer, D. A. (1992). Angiogenesis in the female reproductive system. FASEB Journal 6, 886-92.

Risau, W. (1991). In Growth factors and matrix influences, R. N. Feinberg, et al., ed.(Basel: Karger), 58.

Risau, W. (1995). Differentiation of endothelium. FASEB Journal 9, 926-33.

Risau, W., Drexler, H., Mironov, V., Smits, A., Siegbahn, A., Funa, K., and Heldin, C. H. (1992). Platelet-derived growth factor is angiogenic in vivo. Growth Factors 7, 261-6.

Risau, W., and Lemmon, V. (1988). Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Developmental Biology 125, 441-50.

Risau, W., Sariola, H., Zerwes, H. G., Sasse, J., Ekblom, P., Kemler, R., and Doetschman, T. (1988). Vasculogenesis and angiogenesis in embryonic-stem-cell-derived embryoid bodies. Development 102, 471-8.

Roberts, A. B., Sporn, M. B., Assoian, R. K., Smith, J. M., Roche, N. S., Wakefield, L. M., Heine, U. I., Liotta, L. A., Falanga, V., and Kehrl, J. H. (1986). Transforming growth factortype beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proceedings of the National Academy of Sciences of the United States of America 83, 4167-71.

Roberts, W. G., and Palade, G. E. (1995). Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. Journal of Cell Science 108, 2369-79.

Rosen, E. M., Grant, D. S., Kleinman, H. K., Goldberg, I. D., Bhargava, M. M., Nickoloff, B. J., Kinsella, J. L., and Polverini, P. (1993). Scatter factor (hepatocyte growth factor) is a potent angiogenesis factor in vivo. Symposia of the Society for Experimental Biology 47, 227-34.

Rosnet, O., Marchetto, S., deLapeyriere, O., and Birnbaum, D. (1991a). Murine Flt3, a gene encoding a novel tyrosine kinase receptor of the PDGFR/CSF1R family. Oncogene 6, 1641-50.

Rosnet, O., Mattei, M. G., Marchetto, S., and Birnbaum, D. (1991b). Isolation and chromosomal localization of a novel FMS-like tyrosine kinase gene. Genomics 9, 380-5.

Rosnet, O., Stephenson, D., Mattei, M. G., Marchetto, S., Shibuya, M., Chapman, V. M., and Birnbaum, D. (1993). Close physical linkage of the FLT1 and FLT3 genes on chromosome 13 in man and chromosome 5 in mouse. Oncogene 8, 173-9.

Ryan, T. J., Mortimer, P. S., and Jones, R. L. (1986). Lymphatics of the skin. Neglected but important. International Journal of Dermatology 25, 411-9.

Sabin, F. R. (1902). On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. The American Journal of Anatomy 1, 367-391.

Sabin, F. R. (1909). The lymphatic system in human embryos, with a consideration of the morphology of the system as a whole. The American Journal of Anatomy 9, 43-91.

Sabin, F. R. (1912). On the origin of the abdominal lymphatics in mammals from the vena cava and renal veins. Anatomical Record 6, 335-343.

Sabin, F. R. (1920). Origin and development of the primitive vessels of the chick and the pig. Contrib. Embryol. Carnegie Inst. 6, 61-124.

Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). Molecular cloning. A laboratory manual. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press).

Sánchez, A., Jones, W. K., Gulick, J., Doetschman, T., and Robbins, J. (1991). Myosin heavy chain gene expression in mouse embryoid bodies. An in vitro developmental study. Journal of Biological Chemistry 266, 22419-26.

Sareneva, T., Pirhonen, J., Cantell, K., Kalkkinen, N., and Julkunen, I. (1994). Role of N-glycosylation in the synthesis, dimerization and secretion of human interferon-gamma. Biochemical Journal 303, 831-40.

Sarzani, R., Arnaldi, G., De Pirro, R., Moretti, P., Schiaffino, S., and Rappelli, A. (1992). A novel endothelial tyrosine kinase cDNA homologous to platelet-derived growth factor receptor cDNA. Biochemical & Biophysical Research Communications 186, 706-14.

Sato, K., Yamazaki, K., Shizume, K., Kanaji, Y., Obara, T., Ohsumi, K., Demura, H., Yamaguchi, S., and Shibuya, M. (1995a). Stimulation by thyroid-stimulating hormone and Grave' s immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. Journal of Clinical Investigation 96, 1295-302.

Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W., and Qin, Y. (1995b). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-4.

Schmelz, M., Moll, R., Kuhn, C., and Franke, W. W. (1994). Complexus adhaerentes, a new group of desmoplakin-containing junctions in endothelial cells: II. Different types of lymphatic vessels. Differentiation 57, 97-117.

Schnürch, H., and Risau, W. (1993). Expression of tie-2, a member of a novel family of receptor tyrosine kinases, in the endothelial cell lineage. Development 119, 957-68.

Schreiber, A. B., Winkler, M. E., and Derynck, R. (1986). Transforming growth factor-alpha:a more potent angiogenic mediator than epidermal growth factor. Science 232, 1250-3.

Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S., and Shibuya, M. (1995). A unique signal transduction from FLT tyrosine kinase, a receptor for vascular endothelial growthfactor VEGF. Oncogene 10, 135-47.

Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S., and Dvorak, H. F. (1983). Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 219, 983-5.

Senger, D. R., Perruzzi, C. A., Feder, J., and Dvorak, H. F. (1986). A highly conserved vascular permeability factor secreted by a variety of human and rodent tumor cell lines. Cancer Research 46, 5629-32.

Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L., and Schuh, A. C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-6.

Shammas, N. W., Moss, A. J., Sullebarger, J. T., Gutierrez, O. H., and Rocco, T. A. (1993). Acquired coronary angiogenesis after myocardial infarction. Cardiology 83, 212-6.

Shapiro, R., Riordan, J. F., and Vallee, B. L. (1986). Characteristic ribonucleolytic activity of human angiogenin [published erratum appeared in Biochemistry 1986 Oct 21;25(21):6730]. Biochemistry 25, 3527-32.

Shen, H., Clauss, M., Ryan, J., Schmidt, A. M., Tijburg, P., Borden, L., Connolly, D., Stern, D., and Kao, J. (1993). Characterization of vascular permeability factor/vascular endothelial growth factor receptors on mononuclear phagocytes. Blood 81, 2767-73.

Sherer, G. K. (1991). The development of the vascular system. (Basel: Karger).

Shibuya, M. (1995). Role of VEGF-flt receptor system in normal and tumor angiogenesis. Advances in Cancer Research 67, 281-316.

Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H., and Sato, M. (1990). Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 5, 519-24.

Shifren, J. L., Doldi, N., Ferrara, N., Mesiano, S., and Jaffe, R. B. (1994). In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action. Journal of Clinical Endocrinology &Metabolism 79, 316-22.

Shima, D. T., Adamis, A. P., Ferrara, N., Yeo, K. T., Yeo, T. K., Allende, R., Folkman, J., and D'Amore, P. A. (1995a). Hypoxic induction of endothelial cell growth factors in retinal cells:identification and characterization of vascular endothelial growth factor (VEGF) as the mitogen. Molecular Medicine 1, 182-93.

Shima, D. T., Deutsch, U., and D'Amore, P. A. (1995b). Hypoxic induction of Vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability. FEBS Letters 370, 203-8.

Shima, D. T., Kuroki, M., Deutsch, U., Ng, Y. S., Adamis, A. P., and D'Amore, P. A. (1996). The mouse gene for vascular endothelial growth factor. Genomic structure, definition of the transcriptional unit, and characterization of transcriptional and post-transcriptional regulatorysequences. Journal of Biological Chemistry 271, 3877-83.

Shing, Y., Folkman, J., Haudenschild, C., Lund, D., Crum, R., and Klagsbrun, M. (1985). Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor. Journal of Cellular Biochemistry 29, 275-87.

Sholley, M. M., Ferguson, G. P., Seibel, H. R., Montour, J. L., and Wilson, J. D. (1984). Mechanisms of neovascularization. Vascular sprouting can occur without proliferation of endothelial cells. Laboratory Investigation 51, 624-34.

Shweiki, D., Itin, A., Neufeld, G., Gitay-Goren, H., and Keshet, E. (1993). Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. Journal of Clinical Investigation 91, 2235-43.

Shweiki, D., Itin, A., Soffer, D., and Keshet, E. (1992). Vascular endothelial growthfactor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359, 843-5.

Shweiki, D., Neeman, M., Itin, A., and Keshet, E. (1995). Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proceedings of the National Academy of Sciences of the United States of America 92, 768-72.

Sidky, Y. A., and Borden, E. C. (1987). Inhibition of angiogenesis by interferons: effects on tumor- and lymphocyte-induced vascular responses. Cancer Research 47, 5155-61.

Simon, M., Gröne, H. J., Jöhren, O., Kullmer, J., Plate, K. H., Risau, W., and Fuchs, E. (1995). Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney. American Journal of Physiology 268, F240-50.

Soker, S., Fidder, H., Neufeld, G., and Klagsbrun, M. (1996). Characterization of novel vascular endothelial growth factor (VEGF) receptors on tumor cells that bind VEGF165 via its exon 7-encoded domain. Journal of Biological Chemistry 271, 5761-7.

Stavri, G. T., Zachary, I. C., Baskerville, P. A., Martin, J. F., and Erusalimsky, J. D. (1995). Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. Circulation 92, 11-4.

Stein, I., Neeman, M., Shweiki, D., Itin, A., and Keshet, E. (1995). Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes. Molecular & Cellular Biology 15, 5363-8.

Stevens, A., and Lowe, J. S. (1992). Blood and Lymphatic Circulatory Systems. In Histology,(London: Gower Medical Publishing), 103-123.

Stewart, P. A., and Hayakawa, E. M. (1987). Interendothelial junctional changes underlie developmental 'tightening' of the blood-brain barrier. Brain Research 429, 271-81.

Stone, J., Itin, A., Alon, T., Pe'er, J., Gnessin, H., Chan-Ling, T., and Keshet, E. (1995). Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. Journal of Neuroscience 15, 4738-4747.

Strieter, R. M., Kunkel, S. L., Elner, V. M., Martonyi, C. L., Koch, A. E., Polverini, P. J., and Elner, S. G. (1992). Interleukin-8. A corneal factor that induces neovascularization. American Journal of Pathology 141, 1279-84.

Subramaniam, A., Jones, W. K., Gulick, J., Wert, S., Neumann, J., and Robbins, J. (1991). Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. Journal of Biological Chemistry 266, 24613-20.

Suzuki, K., Hayashi, N., Miyamoto, Y., Yamamoto, M., Ohkawa, K., Ito, Y., Sasaki, Y., Yamaguchi, Y., Nakase, H., Noda, K., Enomoto, N., Arai, K., Yamada, Y., Yoshihara, H., Tujimura, T., Kawano, K., Yoshikawa, K., and Kamada, T. (1996). Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Research 56, 3004-9.

Takagi, H., King, G. L., Ferrara, N., and Aiello, L. P. (in press-a). Hypoxia regulates VEGF receptor KDR/Flk-1 gene expression through adenosine A2 receptors in retinal capillary endothelial cells. Investigative Ophthalmology & Visual Science.

Takagi, H., King, G. L., Ferrara, N., and Aiello, L. P. (in press-b). Hypoxic induction of VEGF is mediated by adenosine through A2 receptors and elevation of cAMP in retinal microvascular pericytes and endothelial cells. Investigative Ophthalmology & Visual Science.

Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. (1995). Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Research 55, 3964-3968.

Takeshita, S., Zheng, L. P., Brogi, E., Kearney, M., Pu, L. Q., Bunting, S., Ferrara, N., Symes, J. F., and Isner, J. M. (1994). Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. Journal of Clinical Investigation 93, 662-70.

Taylor, S., and Folkman, J. (1982). Protamine is an inhibitor of angiogenesis. Nature 297, 307-12.

Tedder, T. F., Steeber, D. A., Chen, A., and Engel, P. (1995). The selectins: vascular adhesion molecules. FASEB Journal 9, 866-73.

Terman, B., Khandke, L., Dougher-Vermazan, M., Maglione, D., Lassam, N. J., Gospodarowicz, D., Persico, M. G., Bohlen, P., and Eisinger, M. (1994). VEGF receptor subtypes KDR and FLT1 show different sensitivities to heparin and placenta growth factor. Growth Factors 11, 187-95.

Terman, B. I., Carrion, M. E., Kovacs, E., Rasmussen, B. A., Eddy, R. L., and Shows, T. B. (1991). Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 6, 1677-83.

Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., and Bohlen, P. (1992a). Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochemical & Biophysical Research Communications 187, 1579-86.

Terman, B. I., Jani-Sait, S., Carrion, M. E., and Shows, T. B. (1992b). The KDR gene maps to human chromosome 4q31.2-q32, a locus which is distinct from locations for other type III growth factor receptor tyrosine kinases. Cytogenetics & Cell Genetics 60, 214-5.

Tessier, D. C., Thomas, D. Y., Khouri, H. E., Laliberte, F., and Vernet, T. (1991). Enhanced secretion from insect cells of a foreign protein fused to the honeybee melittin signal peptide. Gene 98, 177-83.

Tessler, S., Rockwell, P., Hicklin, D., Cohen, T., Levi, B. Z., Witte, L., Lemischka, I. R., and Neufeld, G. (1994). Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors. Journal of Biological Chemistry 269, 12456-61.

Thieme, H., Aiello, L. P., Takagi, H., Ferrara, N., and King, G. L. (1995). Comparative analysis of vascular endothelial growth factor receptors on retinal and aortic vascular endothelial cells. Diabetes 44, 98-103.

Thomas, K. A. (1996). Vascular endothelial growth factor, a potent and selective angiogenic agent. Journal of Biological Chemistry 271, 603-6.

Thomas, K. A., Rios-Candelore, M., Gimenez-Gallego, G., DiSalvo, J., Bennett, C., Rodkey, J., and Fitzpatrick, S. (1985). Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1. Proceedings of the National Academy of Sciences of the United States of America 82, 6409-13.

Tischer, E., Gospodarowicz, D., Mitchell, R., Silva, M., Schilling, J., Lau, K., Crisp, T., Fiddes, J. C., and Abraham, J. A. (1989). Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochemical & Biophysical Research Communications 165, 1198-206.

Tolsma, S. S., Volpert, O. V., Good, D. J., Frazier, W. A., Polverini, P. J., and Bouck, N. (1993). Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity. Journal of Cell Biology 122, 497-511.

Tomanek, R. J. (1970). Effects of age and exercise on the extent of the myocardial capillary bed. Anatomical Record 167, 55-62.

Tomanek, R. J., and Torry, R. J. (1994). Growth of the coronary vasculature in hypertrophy:mechanisms and model dependence. Cellular & Molecular Biology Research 40, 129-36.

Tsai, J. C., Goldman, C. K., and Gillespie, G. Y. (1995). Vascular endothelial growthfactor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. Journal of Neurosurgery 82, 864-73.

Ullrich, A., and Schlessinger, J. (1990). Signal transduction by receptors with tyrosine kinase activity. Cell 61, 203-12.

Unemori, E. N., Ferrara, N., Bauer, E. A., and Amento, E. P. (1992). Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. Journal of Cellular Physiology 153, 557-62.

Vaisman, N., Gospodarowicz, D., and Neufeld, G. (1990). Characterization of the receptors for vascular endothelial growth factor. Journal of Biological Chemistry 265, 19461-6.

van der Geer, P., Hunter, T., and Lindberg, R. A. (1994). Receptor protein-tyrosine kinases and their signal transduction pathways. Annual Review of Cell Biology 10, 251-337.

Van Meir, E. G., Polverini, P. J., Chazin, V. R., Su Huang, H. J., de Tribolet, N., and Cavenee, W. K. (1994). Release of an inhibitor of angiogenesis upon induction of wild type P53 expression in glioblastoma cells. Nature Genetics 8, 171-6.

van Mourik, J. A., von dem Borne, A. E., and Giltay, J. G. (1990). Pathophysiological significance of integrin expression by vascular endothelial cells. Biochemical Pharmacology 39, 233-9.

Vassar, R., and Fuchs, E. (1991). Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes & Development 5, 714-27.

Vassar, R., Rosenberg, M., Ross, S., Tyner, A., and Fuchs, E. (1989). Tissue-specific and differentiation-specific expression of a human K14 keratin gene in transgenic mice. Proceedings of the National Academy of Sciences of the United States of America 86, 1563-7.

Vaughn, J. L., Goodwin, R. H., Tompkins, G. J., and McCawley, P. (1977). The establishment of two cell lines from the insect Spodoptera frugiperda (Lepidoptera; Noctuidae). In Vitro 13, 213-7.

Viglietto, G., Maglione, D., Rambaldi, M., Cerutti, J., Romano, A., Trapasso, F., Fedele, M., Ippolito, P., Chiappetta, G., Botti, G., and et al. (1995). Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene 11, 1569-79.

Vincenti, V., Cassano, C., Rocchi, M., and Persico, G. (1996). Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 93, 1493-5.

Volpert, O. V., Stellmach, V., and Bouck, N. (1995). The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression. Breast Cancer Research & Treatment 36, 119-26.

von Kirschhofer, K., Grim, M., Christ, B., and Wachtler, F. (1994). Emergence of myogenic and endothelial cell lineages in avian embryos. Developmental Biology 163, 270-8.

Wahl, S. M., Hunt, D. A., Wakefield, L. M., McCartney-Francis, N., Wahl, L. M., Roberts, A. B., and Sporn, M. B. (1987). Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proceedings of the National Academy of Sciences of the United States of America 84, 5788-92.

Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., and Heldin, C.-H. (1994). Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. Journal of Biological Chemistry 269, 26988-26995.

Wang, X.-F., Lin, H. Y., Ng-Eaton, E., Downward, J., Lodish, H. F., and Weinberg, R. A. (1991). Expression cloning and characterization of the TGF-beta type III receptor. Cell 67, 797-805.

Warren, R. S., Yuan, H., Matli, M. R., Gillett, N. A., and Ferrara, N. (1995). Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. Journal of Clinical Investigation 95, 1789-97.

Warrington, J. A., Bailey, S. K., Armstrong, E., Aprelikova, O., Alitalo, K., Dolganov, G. M., Wilcox, A. S., Sikela, J. M., Wolfe, S. F., Lovett, M., and et al. (1992). A radiation hybrid map of 18 growth factor, growth factor receptor, hormone receptor, or neurotransmitter receptor genes on the distal region of the long arm of chromosome 5. Genomics 13, 803-8.

Wei, M. H., Popescu, N. C., Lerman, M. I., Merrill, M. J., and Zimonjic, D. B. (1996). Localization of the human vascular endothelial growth factor gene, VEGF, at chromosome 6p12. Human Genetics 97, 794-7.

Weidner, N. (1995). Intratumor microvessel density as a prognostic factor in cancer [comment]. American Journal of Pathology 147, 9-19.

Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., and Folkman, J. (1993). Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. American Journal of Pathology 143, 401-9.

Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. (1991). Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. New England Journal of Medicine 324, 1-8.

Weingast, G. R., Hopper, K. D., Gottesfeld, S. A., and Manco-Johnson, M. L. (1988). Congenital lymphangiectasia with fetal cystic hygroma: report of two cases with coexistent Down's syndrome. Journal of Clinical Ultrasound 16, 663-8.

West, D. C., Hampson, I. N., Arnold, F., and Kumar, S. (1985). Angiogenesis induced by degradation products of hyaluronic acid. Science 228, 1324-6.

Wickham, T. J., and Nemerow, G. R. (1993). Optimization of growth methods and recombinant protein production in BTI-Tn-5B1-4 insect cells using the baculovirus expression system. Biotechnology Progress 9, 25-30.

Wilms, P., Christ, B., Wilting, J., and Wachtler, F. (1991). Distribution and migration of angiogenic cells from grafted avascular intraembryonic mesoderm. Anatomy & Embryology 183, 371-7.

Wilson, D. (1983). The origin of the endothelium in the developing marginal vein of the chick wing-bud. Cell Differentiation 13, 63-7.

Wilting, J., Birkenhager, R., Eichmann, A., Kurz, H., Martiny-Baron, G., Marme, D., McCarthy, J. E., Christ, B., and Weich, H. A. (1996). VEGF121 induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of chorioallantoic membrane. Developmental Biology 176, 76-85.

Wilting, J., and Christ, B. (1996b). Embryonic angiogenesis: a review. Naturwissenschaften 83, 153-64.

Wilting, J., Christ, B., and Bokeloh, M. (1991). A modified chorioallantoic membrane (CAM) assay for qualitative and quantitative study of growth factors. Studies on the effects of carriers, PBS, angiogenin, and bFGF. Anatomy & Embryology 183, 259-71.

Wolff, J. E., Guerin, C., Laterra, J., Bressler, J., Indurti, R. R., Brem, H., and Goldstein, G. W. (1993). Dexamethasone reduces vascular density and plasminogen activator activity in 9Lrat brain tumors. Brain Research 604, 79-85.

Wrana, J. L., Attisano, L., Wieser, R., Ventura, F., and Massague, J. (1994). Mechanism of activation of the TGF-beta receptor. Nature 370, 341-7.

Wysolmerski, J. J., Broadus, A. E., Zhou, J., Fuchs, E., Milstone, L. M., and Philbrick, W. M. (1994). Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interferes with hair follicle development. Proceedings of the National Academy of Sciences of the United States of America 91, 1133-7.

Yamaguchi, T. P., Dumont, D. J., Conlon, R. A., Breitman, M. L., and Rossant, J. (1993). flk-1, an flt-related receptor tyrosine kinase is an early marker for endothelial cell precursors. Development 118, 489-98.

Yamane, A., Seetharam, L., Yamaguchi, S., Gotoh, N., Takahashi, T., Neufeld, G., and Shibuya, M. (1994). A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1and KDR/Flk-1). Oncogene 9, 2683-90.

Yang, R., Thomas, G. R., Bunting, S., Ko, A., Keyt, B., Ferrara, N., Ross, J., and Jin, H. (1996). Effects of VEGF on hemodynamics and cardiac performance. Journal of Cardiovascular Pharmacology 27, 838-44.

Yarden, Y., and Ullrich, A. (1988). Growth factor receptor tyrosine kinases. Annual Review of Biochemistry 57, 443-78.

Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., and Ornitz, D. M. (1991). Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 64, 841-8.

Yeo, T. K., Senger, D. R., Dvorak, H. F., Freter, L., and Yeo, K. T. (1991). Glycosylation is essential for efficient secretion but not for permeability-enhancing activity of vascular permeability factor (vascular endothelial growth factor). Biochemical & Biophysical Research Communications 179, 1568-75.

Zadvinskis, D. P., Benson, M. T., Kerr, H. H., Mancuso, A. A., Cacciarelli, A. A., Madrazo, B. L., Mafee, M. F., and Dalen, K. (1992). Congenital malformations of the cervicothoracic lymphatic system: embryology and pathogenesis. Radiographics 12, 1175-89.

Zeng, X., Wert, S. E., Federici, R., Peters, K. G., and Whitsett, J. A. (submitted). Expression of VEGF in the respiratory epithelium enhances vasculogenesis and disrupts lung morphogenesis in vivo. EMBO Journal.

Zhang, H. T., Craft, P., Scott, P. A., Ziche, M., Weich, H. A., Harris, A. L., and Bicknell, R. (1995). Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells. Journal of the National Cancer Institute 87, 213-9.

Zhang, Y., Deng, Y., Luther, T., Muller, M., Ziegler, R., Waldherr, R., Stern, D. M., and Nawroth, P. P. (1994). Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. Journal of Clinical Investigation 94, 1320-7.

Ziche, M., Morbidelli, L., Alessandri, G., and Gullino, P. M. (1992). Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. Laboratory Investigation 67, 711-5.